MetaCap

MacroGenics Statistics

NASDAQ: MGNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.96-0.02 (-1.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MacroGenics by the numbers

MacroGenics has a market capitalization of $125.3 million based on 63.91M shares outstanding. With trailing EPS of $-2.30, MacroGenics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.1% below its 50-day average and 43.2% below its 200-day average.

Average daily trading volume is 747.02K shares, or about $1.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MGNX valuation vs. peer median

MGNX compared with the median of 8 peer companies
MetricMGNXPeer medianDifference
Market cap$125.26M$119.34M+5%
Avg. volume747.02K346.13K+116%

Peer median across 8 companies: SION, MSLE, ZNTL, ADAG, ALXO, OKUR, IMUX, MENS.

Valuation

Market cap
$125.26M
Price / sales (latest FY)
0.84
EPS (TTM)
$-2.30

Price and trading

Previous close
1.98
Open
1.96
Day range
1.90 – 2.08
52-week range
1.32 – 5.08
52-week change
+40.00%
Beta
—
Volume
1.52M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
125.26M
Forward Pe
-1.16
Eps
-2.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.08
Week52 Low
1.32
Avg Volume
747.02K
Shares Outstanding
63.91M
Ma50
3.12
Ma200
3.45
Earnings Date
Nov 12, 2026
Pct From52w High
-61.42%
Pct From52w Low
48.48%

Related